Musculoskeletal
Osteoporosis in Postmenopausal Women
February 2001
Clinical Focus*
- What is the role of clinical risk factors, in conjunction with bone measurement tests, in identifying high-risk women and guiding initial treatment decisions?
- What are the advantages and disadvantages of various bone measurement tests at different anatomic sites identifying women at high risk of fracture?
- Are bone measurement tests effective for monitoring response to treatment and for guiding decisions about changes in management?
- What is the role of markers of bone turnover for identifying women at risk of bone loss, guiding initial treatment decisions, or monitoring response to therapy?
- What diagnostic or laboratory tests are appropriate for evaluating patients with osteoporosis, as determined by bone measurement tests or documented vertebral fractures?
- Assuming consistent treatment approaches, what are the costs and cost-effectiveness of various diagnostic strategies for identifying women with osteoporosis?
*Addressed in the summary or evidence report.
Osteoporosis in Postmenopausal Women: Diagnosis and Monitoring
Summary (Publication No. 01-E031, February 2001)
Evidence Report (Publication No. 01-E032, December 2002)
(File Download)
EPC: Oregon Health & Science University
Topic Nominator: National Institute of Arthritis and Musculoskeletal and Skin Diseases
Return to Quick Menu: Evidence Report Topics
Return to Evidence-based Practice